Microalbumin Test vs. Urine Albumin-to-Creatinine Ratio: Clarification
No, the "microalbumin test" is not a separate test from the urine albumin-to-creatinine ratio (ACR)—they are the same test. The term "microalbumin test" is simply colloquial shorthand that clinicians and patients use to refer to the albumin-to-creatinine ratio measurement. 1
Understanding the Terminology
The albumin-to-creatinine ratio (ACR) is the preferred and recommended screening method for detecting microalbuminuria in patients with diabetes and hypertension. 2, 3
The test simultaneously measures both urinary albumin concentration and urinary creatinine concentration, then calculates the ratio by dividing albumin by creatinine. 1
The term "microalbuminuria" itself is actually discouraged by current guidelines—laboratories should no longer use this term, as it falsely suggests minor damage when it actually indicates significant vascular dysfunction and cardiovascular risk. 2, 1
What the Test Actually Measures
The ACR corrects for variations in urine concentration by using creatinine as an internal control, making it far more accurate than measuring albumin concentration alone. 1, 4
Normal ACR is defined as <30 mg/g creatinine, while elevated albumin excretion (formerly called "microalbuminuria") is 30-299 mg/g creatinine. 1, 3
The creatinine component serves only as a normalizing factor—it does not assess kidney function, which must be evaluated separately with serum creatinine and eGFR. 1
Why This Patient Needs the Test
For this 60-year-old man with diabetes, hypertension, and hyperlipidemia, annual ACR screening is mandatory. 3, 4
The American Diabetes Association recommends annual urine albumin excretion testing in all type 2 diabetic patients starting at diagnosis. 3
First morning void specimens are preferred to minimize effects of orthostatic proteinuria and provide the most concentrated, reliable samples. 1, 3
This patient's combination of diabetes, hypertension, and family history of diabetes places him at high risk for both diabetic nephropathy and cardiovascular disease, making ACR screening essential for risk stratification. 1, 4